Hospira Oxaliplatin Injection 100 mg/20 mL vial

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

oxaliplatin, Quantity: 5 mg/mL

Disponible des:

Hospira Australia Pty Ltd

Designació comuna internacional (DCI):

Oxaliplatin

formulario farmacéutico:

Injection, intravenous infusion

Composición:

Excipient Ingredients: tartaric acid; sodium hydroxide; water for injections

Vía de administración:

Intravenous

Unidades en paquete:

1 x 20 mL

clase:

Medicine Listed (Export Only)

tipo de receta:

(S1) This Schedule is intentionally blank

indicaciones terapéuticas:

Oxaliplatin, used in combination with infusional 5-fluorouracil/leucovorin is indicated for: * Adjuvant treatment of stage III colon cancer in patients who have undergone complete resection of the primary tumour * Treatment of advanced colorectal cancer.

Resumen del producto:

Visual Identification: Clear colourless solution practically free of particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store between 20 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estat d'Autorització:

Licence status A

Data d'autorització:

2013-03-25